Page last updated: 2024-09-04

carbapenems and gabexate

carbapenems has been researched along with gabexate in 1 studies

Compound Research Comparison

Studies
(carbapenems)
Trials
(carbapenems)
Recent Studies (post-2010)
(carbapenems)
Studies
(gabexate)
Trials
(gabexate)
Recent Studies (post-2010) (gabexate)
7,3551475,27774353106

Protein Interaction Comparison

ProteinTaxonomycarbapenems (IC50)gabexate (IC50)
Solute carrier family 22 member 2Homo sapiens (human)0.9
Coagulation factor XHomo sapiens (human)4.61
PlasminogenHomo sapiens (human)0.431
Urokinase-type plasminogen activatorHomo sapiens (human)0.431
Serine protease hepsinHomo sapiens (human)0.383
Multidrug and toxin extrusion protein 1Homo sapiens (human)0.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adachi, T; Eguchi, S; Hidaka, M; Matsushima, H; Ono, S; Soyama, A; Takatsuki, M1

Other Studies

1 other study(ies) available for carbapenems and gabexate

ArticleYear
Efficacy of Triple-Drug Therapy to Prevent Pancreatic Fistulas in Patients With High Drain Amylase Levels After Pancreaticoduodenectomy.
    The Journal of surgical research, 2019, Volume: 234

    Topics: Adult; Aged; Aged, 80 and over; Amylases; Carbapenems; Drug Therapy, Combination; Gabexate; Humans; Middle Aged; Octreotide; Pancreatic Fistula; Pancreaticoduodenectomy; Postoperative Complications; Retrospective Studies

2019